Voloridge Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.9M Buy
+329,337
New +$46.1M 0.18% 157
2025
Q2
Sell
-351,624
Closed -$39.4M 1248
2025
Q1
$39.4M Buy
+351,624
New +$36.3M 0.15% 197
2024
Q3
Sell
-2,381,505
Closed -$163M 1239
2024
Q2
$163M Sell
2,381,505
-1,128,634
-32% -$75.3M 0.61% 16
2024
Q1
$257M Buy
+3,510,139
New +$270M 0.94% 10
2023
Q4
Sell
-132,674
Closed -$9.94M 1276
2023
Q3
$9.94M Sell
132,674
-63,575
-32% -$4.89M 0.05% 464
2023
Q2
$15.1M Sell
196,249
-5,334
-3% -$425K 0.07% 358
2023
Q1
$16.7M Sell
201,583
-114,475
-36% -$9.48M 0.08% 329
2022
Q4
$27.1M Buy
+316,058
New +$25M 0.15% 199
2022
Q1
Sell
-63,243
Closed -$4.59M 1494
2021
Q4
$4.59M Buy
+63,243
New +$4.36M 0.03% 759
2020
Q4
Sell
-459,519
Closed -$29M 1411
2020
Q3
$29M Buy
+459,519
New +$31.9M 0.24% 103
2020
Q1
Sell
-70,586
Closed -$4.59M 1202
2019
Q4
$4.59M Buy
+70,586
New +$4.6M 0.09% 292
2019
Q3
Sell
-399,775
Closed -$27M 1121
2019
Q2
$27M Sell
399,775
-889
-0.2% -$58.5K 0.75% 17
2019
Q1
$26M Buy
+400,664
New +$26.6M 0.79% 22
2017
Q3
Sell
-1,369,698
Closed -$96.9M 432
2017
Q2
$96.9M Sell
1,369,698
-469,170
-26% -$31.2M 2.41% 3
2017
Q1
$125M Buy
+1,838,868
New +$129M 3.04% 1
2016
Q2
Sell
-1,045,095
Closed -$96M 341
2016
Q1
$96M Buy
+1,045,095
New +$94.2M 2.25% 5
2014
Q3
Sell
-44,200
Closed -$3.67M 114
2014
Q2
$3.67M Sell
44,200
-117,007
-73% -$9.11M 0.35% 47
2014
Q1
$11.4M Buy
+161,207
New +$12.6M 1.62% 19

Other funds holding GILD

Voloridge Investment Management's GILD Position: Q1 2026 in Review

Voloridge Investment Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 329,337 shares worth $45.9M. The stake represents 0.18% of the portfolio and ranks #157 among its holdings. This is a return to the name: Voloridge Investment Management previously reported a position in GILD as recently as Q1 2025.

Voloridge Investment Management first reported a position in GILD in Q1 2014 and has held it in 18 quarters since. The position peaked at $257M in Q1 2024. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Voloridge Investment Management held 329,337 shares of Gilead Sciences worth $45.9M as of Q1 2026.
  • Gilead Sciences was a new Voloridge Investment Management position in Q1 2026.
  • Gilead Sciences made up 0.18% of Voloridge Investment Management's portfolio in Q1 2026, its #157 holding.
  • Voloridge Investment Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 18 quarters since.
  • Voloridge Investment Management's Gilead Sciences position peaked at $257M in Q1 2024.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.